OncoCareClinic 308
International Clinic
for Cancer Treatment
Cytokinogenetic
Therapy (CGT)
When is Cytokinogenetic Therapy used?
1. Tumor and metastases
- Suitable for patients who have been denied other types of treatment.
- In cases of disease progression and insufficient effectiveness of primary treatment.
- At all stages of the tumor process, including extensive metastasis.
2. Chemotherapy
- Can be used with all chemotherapy regimens and other types of treatment: immunotherapy, radiation therapy, targeted therapy, and hormone therapy.
- We help increase effectiveness and reduce the side effects of chemotherapy.
3. Prevention
- For preventing recurrence, for people with a hereditary predisposition to cancer, and for those over 65.
About CGT
Cytokinogenetic Therapy (CGT) is a modern cancer treatment method in the field of immuno-oncology.
The method is aimed at activating the body’s own defense mechanisms and enhancing antitumor immunity.
The goal of CGT is to
- Reduce the tumor;
- Achieve regression of metastases;
- Control the disease;
- Prevent recurrences.
Immune activation
We activate the body’s defenses to fight the tumor.
Personalized approach
We select a treatment regimen based on each patient’s individual characteristics.
Quality-of-life support
To support overall health and maintain activity.
Who is CGT suitable for?
- Patients with cancer at any stage
- During chemotherapy and other treatments
- After completion of primary treatment
- Palliative-care patients
- Patients in remission
- People with a predisposition to cancer (hereditary predisposition, genetic mutations, oncogenic HPV strains, benign neoplasms).
- People over 65
Compatible with all types of treatment
Comprehensive approach
Combining cytokinogenetic therapy with other types of treatment produces more effective results
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Targeted therapy
- Hormone therapy
- Can be used as monotherapy
Treatment stages
Call or website request
The clinic administrators will select a convenient time for your consultation.
Consultations are held ONLINE via telemedicine or IN PERSON at the clinic at 4A Fadeeva St., Moscow.
Preparing documents
To complete the consultation, you need to provide:
- Oncologist reports confirming the diagnosis
- Recent test results
Oncologist consultation. What does the consultation include?
- Medical history taking
- Assessment of the patient’s condition
- Review of medical history
- Prescription of an individual cytokinogenetic therapy course
Treatment and follow-up support
- If indicated, a program is developed with monitoring of progress.
- Medications are shipped by EMC courier service to all regions of Russia. Delivery is included in the program cost.
- Detailed instructions on how to use the medications are provided. Patients from other cities receive detailed instructions with video materials.
- We are always available. You can ask your attending physician a question free of charge during the clinic’s working hours.
Contraindications
The method is not used in cases of:
- tumors of the hematopoietic system
(leukemias, lymphomas, multiple myeloma) - thyroid tumors
Still have questions?
Request a callback — our coordinator will contact you and answer your questions about CGT in detail.
Your case is reviewed by doctors and oncology experts
The doctor evaluates the diagnosis, previous treatment, examination results, and possible next steps.
Andrey Leonidovich Ilyushin
Candidate of Medical Sciences, Oncologist
Book an appointmentAleksan Zavenovich Aleksanyan
Professor, Doctor of Medical Sciences, highest qualification category, oncologist, radiologist, surgeon
Book an appointmentMohamed Amir Ben Ammar
Oncologist, immunologist, ultrasound physician, laser surgeon, mammologist, surgeon
Book an appointmentArtem Lvovich Kornilov
Oncologist, immunologist
Book an appointmentVladimir Tamazievich Zarkua
Oncologist, urologist, andrologist, ultrasound diagnostics physician
Book an appointmentSafiya Vakhaevna Umarova
Oncologist, obstetrician-gynecologist
Book an appointmentElena Eduardovna Spirochkina
Oncologist, general practitioner
Book an appointmentLevon Andreevich Ashrafyan
Academician of the Russian Academy of Sciences, Professor, Doctor of Medical Sciences, Honored Doctor of the Russian Federation, gynecologic oncologist, obstetrician-gynecologist
Book an appointmentSvetlana Ivanovna Erofeeva
Oncologist, chemotherapy specialist
Book an appointmentVeronika Nikolaevna Zadeya
Candidate of Medical Sciences, Oncologist
Book an appointmentAnna Valeryevna Alyasova
Professor, Doctor of Medical Sciences, Oncologist
Book an appointmentCancer treatment is a complex, multi-stage process. It includes all therapy options currently available in medicine: surgery, drug therapy, radiation therapy, and rehabilitation. Depending on the stage and morphological subtype of the disease, the doctor determines the most effective treatment strategy. Therefore, you should be prepared for long-term treatment. If you have an advanced form of the disease, treatment may be lifelong; in this case, the main goal of therapy is to prolong life as much as possible while preserving its quality.
- Cytokinogenetic therapy combined with chemotherapy, targeted therapy, or immunotherapy increases the effectiveness of the ongoing treatment by 60–70%, depending on tumor location, morphology, and the extent of the tumor process.
- Cytokinogenetic therapy is advisable in combination with neoadjuvant therapy, as it increases the radicality of the subsequent surgery.
- In the postoperative period, cytokinogenetic therapy, both in combination with chemotherapy and as monotherapy, helps reduce the risk of recurrence and disease progression threefold.
When cytokinogenetic therapy and chemotherapy are used together, chemotherapy toxicity is reduced by 70–80%. Nausea, dysbiosis, and the risk of anemia, leukopenia, and thrombocytopenia decrease. Thanks to cytokinogenetic therapy, patients’ quality of life improves significantly during chemotherapy. This method also helps avoid forced long breaks between chemotherapy courses, when patients need to recover their health in order to continue treatment.
The combination of radiation therapy and cytokinogenetic therapy also increases the overall treatment effect by 30%, while radiation therapy tolerability improves by 50%. The toxic effect on bone marrow is reduced, helping avoid leukopenia, anemia, and thrombocytopenia and reduce inflammatory reactions in the irradiated area.
The effect of cytokinogenetic therapy is assessed after at least 4–6 treatment courses using laboratory and instrumental examination methods (TNF level, CT, MRI, PET/CT) and a standardized quality-of-life questionnaire.
Our method is based on genetic diagnostics and the use of medicinal products based on TNF and IFN-γ. You can read more about the method here. Its key features are high efficacy and good tolerability, as well as the ability to combine it with any other oncology therapy methods. The method can be used at any stage of antitumor treatment, including in patients who have exhausted all other treatment options.